OQROGet OQRO Pro
Insider trade

Corcept Therapeutics (CORT)Director sold ~$159K

Daniel N Jr Swisher, Director at Corcept Therapeutics, sold ~$159K of Corcept Therapeutics shares.

~$159K
Approx. value · 2,200 sh @ $72.45
Traded
Sep 10, 2025
Filed
Sep 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 10, 2025InsiderDirector sold ~$156K of CORT shares in the open market
  2. Jul 17, 2025Insider · 4 peopleInsiders: 4 sales (~$969K)
  3. Jul 18, 2025Insider · 3 peopleInsiders: 3 sales (~$86K)
  4. Aug 1, 2025Insider · 3 peopleInsiders: 7 sales (~$5.5M)
  5. Aug 5, 2025InsiderOfficer sold ~$1K of CORT shares in the open market
  6. Aug 8, 2025InsiderOfficer sold ~$2.51M of CORT shares in the open market
  7. Aug 11, 2025InsiderDirector sold ~$159K of CORT shares in the open market
  8. Aug 22, 2025InsiderOfficer sold ~$166K of CORT shares in the open market
  9. Sep 2, 2025Insider · 4 peopleInsiders: 8 sales (~$6.0M)
  10. Sep 10, 2025 · this disclosureInsiderDirector sold ~$159K of CORT shares in the open market

What came next

  1. Oct 6, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 6, 2025, Gillian Cannon, Ph.D., notified the Board of Directors (the “Board”) of Corcept Therapeutics Incorporated (the “Company”) of her resignation from the Board, effective as of October 10, 2025 (the “Effective Date”).”
  2. Oct 7, 2025InsiderOfficer sold ~$1.8M of CORT shares in the open market
  3. Oct 10, 2025Company filing · Form 8-K · Agreement endedEnded an important agreement
  4. Oct 10, 2025InsiderDirector sold ~$193K of CORT shares in the open market
  5. Nov 3, 2025Insider · 3 peopleInsiders: 3 sales (~$2.7M)
  6. Nov 4, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  7. Nov 5, 2025Insider · 2 peopleInsiders: 6 sales (~$3.7M)
  8. Nov 25, 2025Insider · 1 personInsiders: 2 sales (~$728K)
  9. Dec 1, 2025Insider · 3 peopleInsiders: 3 sales (~$5.2M)
  10. Dec 2, 2025Insider · 1 personInsiders: 2 sales (~$1.6M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Corcept Therapeutics

For Corcept Therapeutics, OQRO holds 64 insider filings (SEC Form 4 or Form 144) and 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CORT page.

Other recent filings by Daniel N Jr Swisher, Director

The full history of Daniel N Jr Swisher, Director is on the profile page.

How this filing works

Other disclosures at Corcept Therapeutics

Everything OQRO holds on this company is on its CORT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data